hCG Dynamics in Early Pregnancy: Timeline, Variability, and Clinical Interpretation
Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced by syncytiotrophoblast after implantation. Its trajectory guides early pregnancy assessment.
Expected Timeline (Singleton, LMP Dating)
| Gestational Age (weeks from LMP) | hCG Range (mIU/mL) | Clinical Context |
| 3 (implantation) | 5–50 | Pre-test; may be negative |
| 4 | 50–500 | Early detection window |
| 5 | 100–5,000 | Most home tests positive |
| 6 | 1,000–50,000 | Doubling ~48h |
| 7–8 | 7,000–200,000 | Peak acceleration |
| 8–10 | 20,000–250,000 | Peak levels |
| 12–16 | 10,000–100,000 | Decline & plateau |
| 2nd/3rd Trimester | 5,000–50,000 | Stable, lower |
Key Kinetic Principles
- Doubling Time: ~48h (range 36–72h) in viable early pregnancy (<6000 mIU/mL). Slows as levels rise.
- Discriminatory Zone: ~1500–2000 mIU/mL (transvaginal US should visualize IUP).
- Non-Viable Patterns: Suboptimal rise (<53% in 48h), plateau, or decline → ectopic or failed IUP.
Sources of Variability
- Maternal weight (inverse correlation — volume of distribution).
- Multiple gestation (↑ hCG, not 2×).
- Gestational age dating error (ovulation variability).
- Assay differences (WHO standards vs. proprietary).
Clinical Pearls
- Single hCG is insufficient — serial q48h required for viability assessment.
- Home test: Wait ≥1 week after missed period for reliability.
- hCG ≠ progesterone; both needed for comprehensive evaluation.
- Post-loss: hCG declines exponentially (half-life ~24–36h); follow to <5 mIU/mL.
Quantitative serial hCG + ultrasound = standard for early pregnancy triage.
Pregnancy & Health - Related Articles